220 related articles for article (PubMed ID: 24681730)
21. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
[TBL] [Abstract][Full Text] [Related]
22. [The expression of RhoC and Ki67 in cervical intraepithelial neoplasia and squamous carcinoma of cervix].
Nai MM; Yin RT; Xie C; Kang DY; Tang XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):236-9. PubMed ID: 19462897
[TBL] [Abstract][Full Text] [Related]
23. In vivo cyclin E expression as a marker for early cervical neoplasia.
Quade BJ; Park JJ; Crum CP; Sun D; Dutta A
Mod Pathol; 1998 Dec; 11(12):1238-46. PubMed ID: 9872657
[TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of nuclear factor κB contributes to cystic fibrosis transmembrane conductance regulator expression and promotes human cervical cancer progression and poor prognosis.
Wu Z; Peng X; Li J; Zhang Y; Hu L
Int J Gynecol Cancer; 2013 Jun; 23(5):906-15. PubMed ID: 23640294
[TBL] [Abstract][Full Text] [Related]
25. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang H; Wang M; Lian G; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):99-102. PubMed ID: 23353165
[TBL] [Abstract][Full Text] [Related]
26. Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma.
Ha SY; Kim SH
Pathol Res Pract; 2012 Aug; 208(8):462-9. PubMed ID: 22766604
[TBL] [Abstract][Full Text] [Related]
27. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang HR; Wang MH; Lian GY; Wu DG
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):99-102. PubMed ID: 25613619
[TBL] [Abstract][Full Text] [Related]
28. Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2).
Changchien YC; Tátrai P; Papp G; Sápi J; Fónyad L; Szendrői M; Pápai Z; Sápi Z
J Transl Med; 2012 Oct; 10():216. PubMed ID: 23110793
[TBL] [Abstract][Full Text] [Related]
29. TOP2A/MCM2, p16
Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
[TBL] [Abstract][Full Text] [Related]
30. [Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions].
Lin J; Zhang P; Pang L; Chen J; Sun W; Qi W; Lyu Y; Guan H; Gao J
Zhonghua Fu Chan Ke Za Zhi; 2016 Jan; 51(1):40-5. PubMed ID: 26899006
[TBL] [Abstract][Full Text] [Related]
31. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
[TBL] [Abstract][Full Text] [Related]
32. EZH2 expression in invasive lobular carcinoma of the breast.
Roh S; Park SY; Ko HS; Sohn JS; Cha EJ
World J Surg Oncol; 2013 Nov; 11():299. PubMed ID: 24266940
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations.
Dellas A; Moch H; Schultheiss E; Feichter G; Almendral AC; Gudat F; Torhorst J
Gynecol Oncol; 1997 Oct; 67(1):27-33. PubMed ID: 9345352
[TBL] [Abstract][Full Text] [Related]
34. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
35. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
[TBL] [Abstract][Full Text] [Related]
37. Classification of high-grade cervical intraepithelial neoplasia by p16
Vink FJ; Dick S; Heideman DAM; De Strooper LMA; Steenbergen RDM; Lissenberg-Witte BI; ; Floore A; Bonde JH; Oštrbenk Valenčak A; Poljak M; Petry KU; Hillemanns P; van Trommel NE; Berkhof J; Bleeker MCG; Meijer CJLM
Int J Cancer; 2021 Aug; 149(3):707-716. PubMed ID: 33729551
[TBL] [Abstract][Full Text] [Related]
38. Expression of PBK/TOPK in cervical cancer and cervical intraepithelial neoplasia.
Luo Q; Lei B; Liu S; Chen Y; Sheng W; Lin P; Li W; Zhu H; Shen H
Int J Clin Exp Pathol; 2014; 7(11):8059-64. PubMed ID: 25550851
[TBL] [Abstract][Full Text] [Related]
39. EZH2, Endothelin-1, and CD34 as Biomarkers of Aggressive Cervical Squamous Cell Carcinoma: An Immunohistochemical Study.
Fathy A; Abdelrahman AE
Turk Patoloji Derg; 2018; 34(2):150-57. PubMed ID: 29630085
[TBL] [Abstract][Full Text] [Related]
40. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
